dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Alcubierre, Nuria |
dc.contributor.author | Granado-Casas, Minerva |
dc.contributor.author | Bogdanov Baruj, Patricia |
dc.contributor.author | Hernández Pascual, Cristina |
dc.contributor.author | Ramos Abellan, Hugo |
dc.contributor.author | Castelblanco, Esmeralda |
dc.contributor.author | Simó Canonge, Rafael |
dc.date.accessioned | 2023-03-29T10:26:25Z |
dc.date.available | 2023-03-29T10:26:25Z |
dc.date.issued | 2023-02-25 |
dc.identifier.citation | Alcubierre N, Granado-Casas M, Bogdanov P, Hernández C, Ramos H, Castelblanco E, et al. Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies. Nutrients. 2023 Feb 25;15(5):1169. |
dc.identifier.issn | 2072-6643 |
dc.identifier.uri | https://hdl.handle.net/11351/9267 |
dc.description | Consum de cafeïna; Consum de te; Diabetis tipus 2 |
dc.description.sponsorship | This research was funded by grant PS09/01035 from Instituto de Salud Carlos III. N.A. and M.G-C. held a predoctoral fellowship from ISCIII (FI11/0008) and Ministerio de Educación, Cultura y Deporte (FPU15/03005), respectively. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM; the current study was led by group CB15/00071) and CIBER Epidemiología y Salud Pública (CIBERESP) are an initiative from the Instituto de Salud Carlos III (Plan Nacional de I + D + I and Fondo Europeo de Desarrollo Regional). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Nutrients;15(5) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Retinopatia diabètica - Factors de risc |
dc.subject | Diabetis no-insulinodependent - Complicacions |
dc.subject | Cafeïna |
dc.subject.mesh | Diabetic Retinopathy |
dc.subject.mesh | Risk Factors |
dc.subject.mesh | Diabetes Mellitus, Type 2 |
dc.subject.mesh | Caffeine |
dc.title | Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/nu15051169 |
dc.subject.decs | retinopatía diabética |
dc.subject.decs | factores de riesgo |
dc.subject.decs | diabetes mellitus tipo II |
dc.subject.decs | cafeína |
dc.relation.publishversion | https://doi.org/10.3390/nu15051169 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Alcubierre N] Avantmedic Center, Lleida, Spain. [Granado-Casas M] Department of Nursing and Physiotherapy, Health Sciences Faculty, University of Lleida, Lleida, Spain. Institute of Biomedical Research in Lleida (IRBLleida), Lleida, Spain. Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain. DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. [Bogdanov P, Hernández C, Ramos H, Simó R] Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain. Grup de Recerca de Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Castelblanco E] DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. Endocrinology, Metabolism and Lipid Research Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA |
dc.identifier.pmid | 36904168 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |